David E. Goel's Net Worth

$1.25 Million

Estimate Recalculated May 20, 2025 11:47PM EST

Who is David E. Goel

David E. Goel has an estimated net worth of $1.25 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, ACELYRIN, Inc., Aura Biosciences, Inc., Zentalis Pharmaceuticals, Inc., POPULAR INC, and ALUMIS INC..

SEC CIK

David E. Goel's CIK is 0001548144

Past Insider Trading and Trends

2013 was David E. Goel's most active year for acquiring shares with 2 total transactions. David E. Goel's most active month to acquire stocks was the month of January. 2020 saw David E. Goel paying a total of $0.00 for 8,888 shares, this is the most they've acquired in one year.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adaptive Biotechnologies Corp

Investor
Updated Mar 10, 2021
Form 4
-6.15%
-806.00K
$39.99
-$32.23M
Mar 10, 2021
12.31M
Sale
Mar 08 - Mar 10
Form 4
5.26K
Feb 17, 2021
5.26K
Grant
Feb 15
Form 4
-13.23%
-2.00M
$40.00
-$80.00M
Jul 22, 2020
13.12M
Sale
Jul 20
Form 4
8.89K
May 11, 2020
8.89K
Grant
Feb 13
Form 4
-12.79%
-2.22M
$26.50
-$58.75M
Jan 28, 2020
15.12M
Options
Jan 24
Form 4
Jul 02, 2019
17.33M
Options
Jul 01
Form 3
Jun 26, 2019
Showing 7 results

Aura Biosciences, Inc.

Investor
Updated Nov 09, 2023
Form 4
29.09%
1.56M
$9.00
$14.04M
Nov 09, 2023
6.92M
Purchase
Nov 09
Form 4
30.39%
1.25M
$12.00
$15.00M
Dec 07, 2022
5.36M
Purchase
Dec 05
Form 4
38.34%
1.78M
$14.00
$24.99M
Nov 04, 2021
6.44M
Purchase
Nov 02
Form 3
Oct 28, 2021
Showing 4 results

Zentalis Pharmaceuticals, Inc.

Investor
Updated Jun 20, 2023
Form 4
51.74%
4.76M
$22.66
$107.86M
Jun 20, 2023
13.96M
Purchase
Jun 20
Form 3
Jun 03, 2022
9.20M
Form 3
Apr 03, 2020
3.82M
Showing 3 results

ACELYRIN, Inc.

Investor
Updated May 11, 2023
Form 4
May 11, 2023
9.33M
Options
May 09
Form 3
May 04, 2023
Showing 2 results

POPULAR INC

Investor
Updated May 10, 2018
Form 4
19.94%
2.13K
May 10, 2018
12.83K
Grant
May 08
Form 4
28.89%
2.34K
May 24, 2017
10.45K
Grant
May 23
Form 4
71.21%
3.32K
Apr 28, 2016
7.97K
Grant
Apr 26
Form 4
30.04%
1.06K
Jun 01, 2015
4.59K
Grant
May 28
Form 4
47.29%
1.13K
Jun 05, 2014
3.53K
Acquisition
Jun 04
Form 4
-100.00%
-466.18K
$28.88
-$13.46M
May 16, 2014
2.40K
Sale
May 14 - May 15
Form 4
-68.20%
-1.00M
$27.64
-$27.64M
Jan 30, 2014
468.57K
Sale
Jan 28 - Jan 30
Form 4
96.24%
1.18K
May 30, 2013
1.47M
Acquisition
May 28
Form 4
1.22K
Feb 14, 2013
1.47M
Acq/Dis
Feb 12
Form 3
May 04, 2012
14.66M
Showing 10 results

ALUMIS INC.

Investor
Updated Jul 03, 2024
Form 4
-59.35%
-27.44M
$16.00
$40.00M
Jul 03, 2024
18.79M
Options
Jul 01
Form 3
Jun 27, 2024
Showing 2 results